US 11,981,690 B2
Alkyl-terminated thiocarbamate complex and method for treating cancer
Anvarhusein A. Isab, Dhahran (SA); and Adam Ahmed Abdullah Sulaiman, Dhahran (SA)
Assigned to KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS, Dhahran (SA)
Filed by KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS, Dhahran (SA)
Filed on May 26, 2022, as Appl. No. 17/825,019.
Application 17/825,019 is a continuation of application No. 16/554,224, filed on Aug. 28, 2019, granted, now 11,384,100.
Prior Publication US 2022/0281897 A1, Sep. 8, 2022
This patent is subject to a terminal disclaimer.
Int. Cl. A61P 35/00 (2006.01); C07F 1/00 (2006.01)
CPC C07F 1/005 (2013.01) [A61P 35/00 (2018.01)] 9 Claims
 
1. A gold(III) complex of formula (I),

OG Complex Work Unit Chemistry
or a pharmaceutically acceptable salt, solvate, tautomer, or stereoisomer thereof, wherein:
R1 and R2 are each independently a hydrogen or an ethyl;
R3 and R4 are each independently a hydrogen;
and X is Cl or Br.
 
5. A pharmaceutical composition, comprising:
the gold(III) complex of formula (I) of claim 1; and
a pharmaceutically acceptable carrier and/or excipient.